Hoth Therapeutics Adopts Lantern Pharma's AI Platform for Drug Development
Hoth Therapeutics is leveraging Lantern Pharma's PredictBBB.ai platform to enhance drug development, as announced in a press release. The AI tool boasts 94% accuracy in predicting blood-brain barrier permeability.